This review summarizes the roles of CD47 in tumor biology, its therapeutic potential in non-small cell lung cancer, and challenges that must be overcome to facilitate the clinical translation of CD47-targeted immunotherapy to improve lung cancer survival rates. The gene discussed is CD47; the disease is neoplasm.